PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Metabolic 'reprogramming' by the p53 gene family leads to tumor regression

Protein IAPP opens potential for diabetes drugs to treat tumors deficient in or lacking p53

Metabolic 'reprogramming' by the p53 gene family leads to tumor regression
2014-11-17
(Press-News.org) Scientists have found that altering members of the p53 gene family, known as tumor suppressor genes, causes rapid regression of tumors that are deficient in or totally missing p53. Study results suggest existing diabetes drugs, which impact the same gene-protein pathway, might be effective for cancer treatment.

The University of Texas MD Anderson Cancer Center investigation showed that, in vivo, the genes p63 and p73 can be manipulated to upregulate or increase levels of IAPP, a protein important for the body's ability to metabolize glucose. IAPP is found in some diabetes drugs already on the market.

The research findings were published in today's issue of Nature.

The study, led by Elsa R. Flores, Ph.D., associate professor of molecular and cellular oncology, centered on p63 and p73 because of the genes' ability to cause tumor regression or spur its growth due to their unique genetic makeup.

"P53 is altered in most human cancers and p53 reactivation suppresses tumors in vivo in mice. This strategy has proven difficult to implement therapeutically. We examined an alternative approach by manipulating the p53 family members, p63 and p73," said Flores.

Flores described two "warring" versions of p63 and p73 that are at odds when it comes to tumor suppression. One version, known as transactivation domain-bearing, is structurally and functionally similar to p53 in their ability to suppress tumors. The other version, which lacks this transactivation domain, actually prevents p53 from stopping tumor growth. Transactivation domains are specific regions within a protein known as a transcription factor that effect further downstream cellular responses.

"The p53 family interacts extensively in cellular processes that promote tumor suppression," said Flores. "Thus, a clear understanding of this interplay in cancer is needed to treat tumors with p53 alterations."

Flores' team found that by deleting the p63 and p73 versions that lacked transactivation domains, they were able to metabolically reprogram cells so that the cancer progression was stopped and reversed in p53-deficient tumors. This was accomplished through increasing levels of IAPP, a gene important to the body's use of insulin. IAPP encodes amylin, chains of amino acids that are co-secreted with insulin. Flores sees IAPP as significant in trying new therapeutic approaches for treating p53-deficient tumors.

"We found that IAPP is involved in tumor regression and that amylin, the protein encoded by the IAPP gene, stops a cell's ability to metabolize glucose, leading to programmed cell death," said Flores. "Pramlintide, a synthetic type of amylin that is currently used to treat type 1 and type 2 diabetes, caused rapid tumor regression in p53-deficient lymphomas of the thymus."

Flores tested Pramlintide on a variety of human cancer cell lines with p53 deletions and mutations and found the drug to be highly effective in inhibiting glucose metabolization and causing programmed cell death.

"This represents a novel strategy to target p53-deficient and mutant cancers," said Flores. She and her team also identified critical receptors on tumor cells with p53 deletions and mutations needed for Pramlintide to induce tumor regression. The receptors represent a potential prognostic marker for determining if Pramlintide will be effective in treating cancer patients with p53 deletions or mutations.

INFORMATION:

Members of Flores' MD Anderson team included Avinashnarayan Venkatanarayan, Payal Raulji, Deepavali Chakravarti, Ph.D., Xiaohua Shu, Ph.D., Santosh Sandur, Ph.D., and Eliot Sanankone, department of molecular and cellular oncology; Kenneth Tsai, M.D., Ph.D., departments of translational molecular pathology and dermatology; William Norton, D.V.M. and Katherine Naff, D.V.M., department of veterinary medicine and surgery; Marc Ramirez, Jaehuk Lee, Charles Kingsley and James Bankson, department of imaging physics; and Jan Parker-Thornburg, department of genetics. Other participating institutions included Baylor College of Medicine, Houston; the Bhabha Atomic Research Center, Mumbai, India; and the University of Houston.

The study was funded by the National Cancer Institute (R01CA160394, R01CA134796, CA16672, and P50CA136411), the Cancer Prevention and Research Institute of Texas (RP120124, RP101243-P5, and RP101502), the Hildegardo E. and Olga M. Flores Foundation, the Mel Klein Foundation, the Leukemia and Lymphoma Society, the Rita Allen Foundation and the V Foundation for Cancer Research.


[Attachments] See images for this press release:
Metabolic 'reprogramming' by the p53 gene family leads to tumor regression

ELSE PRESS RELEASES FROM THIS DATE:

Three popular daffodil varieties determined to be highly salt tolerant

Three popular daffodil varieties determined to be highly salt tolerant
2014-11-17
BALTIMORE, MD - As the world's diminishing fresh water resources are increasing allocated for human use, agricultural and horticultural production operations must rely more often on the use of brackish, saline, or reclaimed water for irrigation. These saline-rich water sources often contain electrical conductivities that can negativity affect plants' ability to thrive. Salinity is particularly problematic for ornamental plants such as daffodils because of the potential for damage to plants' aesthetics and visual qualities. In the September 2014 issue of HortScience, Maren ...

Mayo Clinic researchers: TNF inhibitors may increase cancer risk in the eye

2014-11-17
ROCHESTER, Minn. -- One of the family of drugs prescribed for rheumatoid arthritis and other inflammatory conditions is called TNF inhibitors. They act by dampening part of the immune system called tumor necrosis factor (TNF). In one of the balancing acts of medicine, the anti-inflammatory action of the drug also increases the risk for other conditions, in this case, a rare form of eye cancer, uveal melanoma. Mayo Clinic researchers make the case and alert physicians in an article in Mayo Clinic Proceedings. Mayo researchers studied three patients -- two women and a ...

Setting family rules promotes healthier behavior in children

Setting family rules promotes healthier behavior in children
2014-11-17
Who says your kids don't listen to you? An Indiana University study has found that setting specific family rules about healthy eating and sedentary behavior actually leads to healthier practices in children. Data analyzed for the study was originally part of a data set used to evaluate the Wellborn Baptist Foundation's HEROES program, a K-12 school-based obesity prevention initiative set in the Illinois, Indiana and Kentucky tri-state area. However, lead author Alyssa M. Lederer, doctoral candidate and associate instructor in the Department of Applied Health Science ...

Researchers find gene in kidney may play role in high blood pressure in male mice

2014-11-17
CINCINNATI--Researchers at the University of Cincinnati (UC) have found that a gene abundant in the kidneys may actually play a role in the regulation of blood pressure and hypertension in experimental male mouse models. The study led by Manoocher Soleimani, MD, James F. Heady Professor of Medicine and associate chair of research in the Department of Internal Medicine at UC, was presented during the annual meeting of the American Society of Nephrology, held Friday, Nov. 15, 2014, in Philadelphia. The gene, a kidney androgen-regulated protein (KAP) that is abundantly ...

New NASA and NSBRI report on sex and gender differences in adaptation to space flight

New NASA and NSBRI report on sex and gender differences in adaptation to space flight
2014-11-17
New Rochelle, NY, November 17, 2014--In the future, as space exploration takes astronauts on longer missions and more female astronauts participate, "The Impact of Sex and Gender on Adaptation to Space" will become increasingly critical to astronaut safety and mission success, as explored in a special collection of articles published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The articles are available Open Access on the Journal of Women's Health website at http://online.liebertpub.com/toc/jwh/23/11. In the Executive ...

Clues to trees' salt tolerance found in native habitat, leaf traits

2014-11-17
LOGAN, UT - Urban landscape plants are often subjected to environmental conditions well beyond those of their native habitat. Differences in precipitation, along with stress caused by increased salinity resulting from irrigation with brackish reclaimed water, can have devastating impacts on trees and plants. Use of salt-tolerant species and implementation of proper management strategies can reduce the incidence of plant stress and loss. Researchers in Utah looked to plants' native habitats for ways to identify salt tolerance among tree species used in urban landscapes in ...

Scientists X-ray tiny cell organelles responsible for carbon fixation

Scientists X-ray tiny cell organelles responsible for carbon fixation
2014-11-17
An international team of scientists led by Uppsala University has developed a high-throughput method of imaging biological particles using an X-ray laser. The images show projections of the carboxysome particle, a delicate and tiny cell compartment in photosynthetic bacteria. The experiment, described in a paper published today in the scientific journal Nature Photonics, represents a major milestone for studies of individual biological structures using X-ray lasers. The technique paves the way for 3D imaging of parts of the cell, and even small viruses, to develop a ...

Complementary and alternative medicine for veterans and military personnel -- update from Medical Care

2014-11-17
November 17, 2014 - A growing body of research evidence shows that complementary and alternative medicine (CAM) has health benefits for US military veterans and active duty personnel, according to a special December supplement to Medical Care. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. The special issue presents new studies and commentaries on the benefits and increasing use of CAM techniques in the Veterans Health Administration (VHA) and other military health settings. "The papers in this supplement represent promising ...

Fatigue, irritability, and demoralization can affect your heart health

2014-11-17
Fatigue, increased irritability, and feeling demoralized, may raise a healthy man or woman's risk of first-time cardiovascular disease by 36 percent, according to a study led by researchers at Mount Sinai St. Luke's and Mount Sinai Roosevelt hospitals presented on Nov. 17 at the American Heart Association's Scientific Sessions 2014 in Chicago, IL. The combination of fatigue, increased irritability, and feeling demoralized is medically known as vital exhaustion. In their study, Mount Sinai researchers found that vital exhaustion was associated with a dramatic increase ...

New insights that link Fragile X syndrome and autism spectrum disorders

2014-11-17
Fragile X syndrome (FXS) is the most common cause of inherited intellectual disability (ID), as well as the most frequent monogenic cause of autism spectrum disorders (ASD). FXS is caused by the absence or incorrect production of the protein FMRP (Fragile X Mental Retardation Protein). Scientists at VIB and KU Leuven (Belgium), in collaboration with Tor Vergata University (Italy) and VU University of Amsterdam (The Netherlands) have pinpointed a novel role that FMRP plays during the embryonic development of the brain cortex. The study reveals that the absence of FMRP leads ...

LAST 30 PRESS RELEASES:

New perspective highlights urgent need for US physician strike regulations

An eye-opening year of extreme weather and climate

Scientists engineer substrates hostile to bacteria but friendly to cells

New tablet shows promise for the control and elimination of intestinal worms

Project to redesign clinical trials for neurologic conditions for underserved populations funded with $2.9M grant to UTHealth Houston

Depression – discovering faster which treatment will work best for which individual

Breakthrough study reveals unexpected cause of winter ozone pollution

nTIDE January 2025 Jobs Report: Encouraging signs in disability employment: A slow but positive trajectory

Generative AI: Uncovering its environmental and social costs

Lower access to air conditioning may increase need for emergency care for wildfire smoke exposure

Dangerous bacterial biofilms have a natural enemy

Food study launched examining bone health of women 60 years and older

CDC awards $1.25M to engineers retooling mine production and safety

Using AI to uncover hospital patients’ long COVID care needs

$1.9M NIH grant will allow researchers to explore how copper kills bacteria

New fossil discovery sheds light on the early evolution of animal nervous systems

A battle of rafts: How molecular dynamics in CAR T cells explain their cancer-killing behavior

Study shows how plant roots access deeper soils in search of water

Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs

‘What is that?’ UCalgary scientists explain white patch that appears near northern lights

How many children use Tik Tok against the rules? Most, study finds

Scientists find out why aphasia patients lose the ability to talk about the past and future

Tickling the nerves: Why crime content is popular

Intelligent fight: AI enhances cervical cancer detection

Breakthrough study reveals the secrets behind cordierite’s anomalous thermal expansion

Patient-reported influence of sociopolitical issues on post-Dobbs vasectomy decisions

Radon exposure and gestational diabetes

EMBARGOED UNTIL 1600 GMT, FRIDAY 10 JANUARY 2025: Northumbria space physicist honoured by Royal Astronomical Society

Medicare rules may reduce prescription steering

Red light linked to lowered risk of blood clots

[Press-News.org] Metabolic 'reprogramming' by the p53 gene family leads to tumor regression
Protein IAPP opens potential for diabetes drugs to treat tumors deficient in or lacking p53